Changing trends in the use of novel oral anticoagulants and warfarin for treating non-valvular atrial fibrillation
{{output}}
Background: Prevention of thromboembolism by novel oral anticoagulants is increasing, whilst use of vitamin K antagonists is on the decline. We assessed changes in the use of these anticoagulants in treating non-valvular atrial f... ...
